The state of Tennessee is taking legal action to block Christa Pike’s attorneys from testing or examining the lethal-injection drug used in her failed execution. Concerns have risen over the possibility that such an examination could reveal the identity of the drug’s manufacturer.
In recent filings, Tennessee Attorney General Jonathan Skrmetti emphasized the risk involved if Pike’s legal team gained access to the drug. According to the attorney general, such access could jeopardize the confidentiality of the state’s lethal-injection supplier, which is protected by Tennessee law.
Pike’s counsel and experts cannot be allowed to see, handle, or otherwise get the information on the leftover vials of pentobarbital from Pike’s attempted execution,
Skrmetti stated in a memo.
An affidavit from a Tennessee Department of Correction employee supported this stance, highlighting the potential loss of access to pentobarbital if the vials were made available to Pike’s defense. The affidavit pointed out that the drug’s packaging reveals the manufacturer’s details.
Concerns about supplier harassment also played a role in the state’s argument. A history of such harassment was noted, with references to a previous supplier cutting ties with Tennessee after its identity was exposed.
As of Wednesday, both Pike’s attorneys and the Tennessee attorney general’s office have not provided any comment on the matter. The state is requesting Judge I’Ashea L. Myles of the Davidson County Chancery Court to reverse her October order, which had allowed Pike’s attorneys access to the remaining lethal injection substance.

Former Hospital Security Guard Convicted for Sexual Conduct with a Dead Body
Northern Illinois University Students Charged After Damaging Mascot Statue
Lindsay Clancy’s Retrial Set for March 29
Former CIA Director’s Son Arrested on Child Pornography Charges
New Charges in White House Correspondents’ Dinner Shooting
New York Fugitive Arrested in Miami Beach for Multiple Assaults